/C O R R E C T I O N -- Ranok Therapeutics/ ...Middle East

In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic Non-Small Cell Lung Cancer Presented At ASCO 2026, issued 01-Jun-2026 by Ranok Therapeutics over PR Newswire, we are advised by...

Hence then, the article about c o r r e c t i o n ranok therapeutics was published today ( Tuesday 02/06/2026 - 01:27 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( /C O R R E C T I O N -- Ranok Therapeutics/ )

Also on site :

• Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2026 ASCO Presentation
• When are London Tube strikes taking place this week and which lines are affected?
• One Night in Mhoon Valley